Dose-dependent protective effect of ivabradine against ischemia- reperfusion-induced renal injury in rats

Kidney and Blood Pressure Research

Volumn 35, Issue 2, 2012, Pages 114-119

  Beytur, Ali ^a   Binbay, Murat ^b   Sarihan, M Ediz ^a   Parlakpinar, Hakan ^a   Polat, Alaadin ^a   Gunaydin, M Orhun ^a   Acet, Ahmet ^a  

^a INONU UNIVERSITY   (Turkey)

^b Haseki Training Hospital   (Turkey)

Author keywords

Endothelial dysfunction; Ivabradine; Oxidative stress; Rat; Renal ischemia

Indexed keywords

ALBUMIN; CATALASE; CREATININE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IVABRADINE; SUPEROXIDE DISMUTASE;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY MASS; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL REPERFUSION; REPERFUSION; SHAM PROCEDURE; SINUS NODE; UREA NITROGEN BLOOD LEVEL;

ANIMALS; BENZAZEPINES; CATALASE; CYCLIC NUCLEOTIDE-GATED CATION CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTATHIONE PEROXIDASE; HEART RATE; KIDNEY; KIDNEY DISEASES; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REPERFUSION INJURY; SINOATRIAL NODE; SUPEROXIDE DISMUTASE;

EID: 80155212934     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000330501     Document Type: Article

References (39)

1. Anaya-Prado R, Toledo-Pereyra LH: The molecular events underlying ischemia-reperfusion injury. Transpl Proc 2002;34:2518-2519.
2. Matin SF, Novick AC: Renal dysfunction associated with staged bilateral partial nephrectomy: the importance of operative positioning. J Urol 2001;165:880-881. (Pubitemid 32156300)
3. Landry GJ, Lau IH, Liem T, Mitchell EL, Moneta GL: Adjunctive renal artery revascularization during juxtarenal and suprarenal abdominal aortic aneurysm repairs. Am J Surg 2010;199:641-645.
4. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M: Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 1998;273:4135-4142. (Pubitemid 28103282)
5. Ricardo SD, Diamond JR: The role of macrophages and reactive oxygen species in experimental hydronephrosis. Semin Nephrol 1998;18:612-621. (Pubitemid 28506733)
6. Yamamoto S, Hagiwara S, Hidaka S, Shingu C, Goto K, Kashima K, Noguchi T: The antioxidant EPC-K1 attenuates renal ischemiareperfusion injury in a rat model. Am J Nephrol 2011;33:485-490.
7. Paller MS, Hoidal J, Ferris TF: Oxygen free radicals in ischemia acute renal failure in rat. J Clin Invest 1984;74:1156-1164. (Pubitemid 15206810)
8. Paller MS: Acute renal failure: controversies, clinical trials, and future. Semin Nephrol 1998;18:482.
9. Akcetin Z, Busch A, Kessler G, Heynemann H, Holtz J, Bromme HJ: Evidence for only a moderate lipid peroxidation during ischemia- reperfusion of rat kidney due to its high antioxidative capacity. Urol Res 1999;27:280-284. (Pubitemid 29431746)
10. Defraigne JO, Detry O, Pincemail J, Franssen C, Meurisse M, Lamy M, Limet R: Direct evidence of free radical production after ischaemia and reperfusion and protective effect of desferrioxamine: ESR and vitamin E studies. Eur J Vasc Surg 1994;8:537-543. (Pubitemid 24270154)
11. Reiter RJ, Guerrero JM, Garcia JJ, Castroviejo D: Reactive oxygen intermediates molecular damage and aging. Relation to melatonin. Ann NY Acad Sci 1998;854:410-424.
12. Drouin A, Gendron ME, Thorin E, Gillis MA, Gaudin FM, Tardif JC: Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice. Brit J Pharmacol 2008;154:749-757. (Pubitemid 351821579)
13. Custodis F, Baumhakel M, Schlimmer N, List F, Gencsh C, Böhm M, Laufs U: Heart rate reduction by ivabradine reduces oxidative stress improves endothelial function and prevents atherosclerosis in apolipoprotein E deficient mice. Circulation 2008;117:2377- 2387.
14. Uchiyama M, Mihara M: Determination of MDA precursor in tissue by TBA test. Anal Biochem 1978;36:271-278.
15. Sun USY, Oberley LW, Li Y: A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500.
16. Aebi H: Catalase; in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1974, pp 673-677.
17. Paglia DE, Valentine WN: Studies on the quantative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-170.
18. Hu W, Chen Z, Ye Z, Xia D, Xia Z, Ma J, Zhu M, Chen G: Knockdown of cyclophilin D gene by RNAi protects rat from ischemia/ reperfusion-induced renal injury. Kidney Blood Press Res 2010;33:193-199.
19. Vela Navarrete R: Re: comparison of cold and warm ischemia during partial nephrectomy in 660 solitary kidneys reveals predominant role of nonmodifiable factors in determining ultimate renal function. Eur Urol 2011;60:181-182.
20. Bagheri F, Gol A, Dabiri S, Javadi A: Preventive effect of garlic juice on renal reperfusion injury. Iran J Kidney Dis 2011;5:194-200.
21. Havasi A, Borkan SC: Apoptosis and acute kidney injury. Kidney Int 2011;80:29-40.
22. Nath KA, Norby SM: Reactive oxygen species and acute renal failure. Am J Med 2000;109:665-678.
23. Paller MS: The cell biology of reperfusion injury in the kidney. J Invest Med 1994;42:632-639.
24. Ozdemir R, Parlakpinar H, Polat A, Colak C, Ermis N, Acet A: Selective endothelin A (ET A) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. Toxicology 2006;219:142-149. (Pubitemid 43120714)
25. Seth P, Kumari R, Madhavan S, Singh AK, Mani H, Banaudha KK, Sharma SC, Kulshreshtha DK, Mahshwari RK: Prevention of renal ischemia reperfusion induced injury in rats by picroliv. Biochem Pharmacol 2000;59:1315-1322. (Pubitemid 30157894)
26. Parlakpinar H, Sahna E, Ozer MK, Ozugurlu F, Vardi N, Acet A: Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury. J Pineal Res 2002;33:161-166.
27. Giovannini L, Migliori M, Longoni BM, Das DK, Bertelli AA, Panichi V, Flippi C, Bertellei A: Resveratrol, a polyphenol found in wine reduces ischemia reperfusion injury in rat kidneys. J Cardiovasc Pharmacol 2001;37:262-270. (Pubitemid 32193504)
28. Parlakpinar H, Olmez E, Acet A, Ozturk F, Tasdemir S, Ates B, Gul M, Otlu A: Beneficial effects of apricot-feeding on myocardial ischemia-reperfusion injury in rats. Food Chem Toxicol 2009;49:802-808.
29. Walker EM, Gale GR: Methods of reduction of cisplatin nephrotoxicity. Ann Clin Lab Sci 1981;11:397-410.
30. Ferrari R, Cargnoni A, Ceconi C: Anti-ischemic effect of ivabradine. Pharm Res 2006;53:435-439.
31. Sulfi S, Timmis AD: Ivabradine - the first selective sinus node I(f) channel inhibitor in the treatment of stable angina. Int J Clin Pract 2006;60:222-228. (Pubitemid 43740503)
32. Sevelieva I, Camm AJ: Novel If current inhibitor ivabradine: safety considerations. Adv Cardiol 2006;43:79-96.
33. Riccioni G: Ivabradine: from molecular basis to clinical effectiveness. Adv Ther 2010;27:160-167.
34. Heusch G: Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction. Brit J Pharmacol 2008;155:970-971.
35. Walcher T, Bernhardt P, Vasic D, Bach H, Durst R, Rottbauer W, Walcher D: Ivabradine reduces chemokine-induced CD4-positive lymphocyte migration. Mediators Inflamm 2010;2010:751313.
36. Baumhäkel M, Custodis F, Schlimmer N, Laufs U, Böhm M: Heart rate reduction with ivabradine improves erectile dysfunction in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice. Atherosclerosis 2010;212:55-62.
37. Zhang RL, Christensen LP, Tomanek RJ: Chronic heart rate reduction facilitates cardiomyocyte survival after myocardial infarction. Anat Rec (Hoboken) 2010;293:839-848.
38. Riccioni G: Ivabradine: recent and potential applications in clinical practice. Expert Opin Pharmacother 2011;12:443-450.
39. Sahna E, Parlakpinar H, Cihan OF, Turkoz Y, Acet A: Effects of aminoguanidine against renal ischemia-reperfusion injury in rats. Cell Biochem Funct 2006;24:137-141.